Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?

HPB

Volumn 17, Issue 5, 2015, Pages 438-446

  Lodewick, Toine M ^a,b,c   Van Nijnatten, Thiemo J A ^a,c   Van Dam, Ronald M ^a,c   Van Mierlo, Kim ^a,c   Dello, Simon A W G ^a   Neumann, Ulf P ^b,c   Olde Damink, Steven W M ^a,c,d,e   Dejong, Cornelis H C ^a,c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d ROYAL FREE HOSPITAL   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL ABSCESS; ABDOMINAL BLEEDING; ADULT; AGED; ARTICLE; ASCITES; BODY COMPOSITION; BODY FAT; BODY MASS; CANCER SURGERY; COLORECTAL LIVER METASTASIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HOSPITAL READMISSION; HUMAN; LIVER FAILURE; LIVER RESECTION; LIVER SURGERY; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBESITY; OVERALL SURVIVAL; SARCOPENIA; SEPSIS; SURGICAL INFECTION; TREATMENT OUTCOME; COLORECTAL NEOPLASMS; COMPLICATION; METASTASIS; MIDDLE AGED; NETHERLANDS; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; SECONDARY; SURVIVAL RATE; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; MALE; MIDDLE AGED; MORBIDITY; NEOPLASM METASTASIS; NETHERLANDS; OBESITY; PROGNOSIS; PROSPECTIVE STUDIES; SARCOPENIA; SURVIVAL RATE; YOUNG ADULT;

EID: 84927563066     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12373     Document Type: Article

References (37)

1. Pawlik TM, Schulick RD, Choti MA, (2008) Expanding criteria for resectability of colorectal liver metastases. Oncologist 13: 51-64.
2. Ansari D, Bergenfeldt M, Tingstedt B, Andersson R, (2012) Multimodal management of colorectal liver metastases and the effect on regeneration and outcome after liver resection. Scand J Gastroenterol 47: 1460-1466.
3. van Dam RM, Lodewick TM, van den Broek MA, de Jong MC, Greve JW, Jansen RL, et al. (2014) Outcomes of extended versus limited indications for patients undergoing a liver resection for colorectal cancer liver metastases. HPB 16: 550-559.
4. Stockmann M, Lock JF, Malinowski M, Niehues SM, Seehofer D, Neuhaus P, (2010) The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB 12: 139-146.
5. Stockmann M, Lock JF, Riecke B, Heyne K, Martus P, Fricke M, et al. (2009) Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann Surg 250: 119-125.
6. Ferrero A, Vigano L, Polastri R, Muratore A, Eminefendic H, Regge D, et al. (2007) Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study. World J Surg 31: 1643-1651.
7. Cauchy F, Zalinski S, Dokmak S, Fuks D, Farges O, Castera L, et al. (2013) Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome. Br J Surg 100: 113-121.
8. Harimoto N, Shirabe K, Yamashita YI, Ikegami T, Yoshizumi T, Soejima Y, et al. (2013) Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg 100: 1523-1530.
9. Peng PD, van Vledder MG, Tsai S, de Jong MC, Makary M, Ng J, et al. (2011) Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB 13: 439-446.
10. van Vledder MG, Levolger S, Ayez N, Verhoef C, Tran TC, Ijzermans JN, (2012) Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 99: 550-557.
11. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, et al. (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69: 491-497.
12. Meza-Junco J, Montano-Loza AJ, Baracos VE, Prado CM, Bain VG, Beaumont C, et al. (2013) Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma. J Clin Gastroenterol 47: 861-870.
13. Dello SA, Lodewick TM, van Dam RM, Reisinger KW, van den Broek MA, von Meyenfeldt MF, et al. (2013) Sarcopenia negatively affects preoperative total functional liver volume in patients undergoing liver resection. HPB 15: 165-169.
14. Schmitz KH, Neuhouser ML, Agurs-Collins T, Zanetti KA, Cadmus-Bertram L, Dean LT, et al. (2013) Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity. J Natl Canc Inst 105: 1344-1354.
15. Wong JY, Shridhar R, Almhanna K, Hoffe SE, Karl RC, Meredith KL, (2013) The impact of body mass index on esophageal cancer. Cancer Control 20: 138-143.
16. Hakimi AA, Furberg H, Zabor EC, Jacobsen A, Schultz N, Ciriello G, et al. (2013) An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. J Natl Canc Inst 105: 1862-1870.
17. Dahlberg SE, Schiller JH, Bonomi PB, Sandler AB, Brahmer JR, Ramalingam SS, et al. (2013) Body mass index and its association with clinical outcomes for advanced non-small-cell lung cancer patients enrolled on Eastern Cooperative Oncology Group clinical trials. J Thorac Oncol 8: 1121-1127.
18. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9: 629-635.
19. Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC, (2009) Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 15: 6973-6979.
20. Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, et al. (2013) Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31: 1539-1547.
21. van Dam RM, Hendry PO, Coolsen MM, Bemelmans MH, Lassen K, Revhaug A, et al. (2008) Initial experience with a multimodal enhanced recovery programme in patients undergoing liver resection. Br J Surg 95: 969-975.
22. Strasberg SM, (2005) Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg 12: 351-355.
23. Dejong CHC, Garden OJ, (2003) Neoplasms of the liver. In:, Majid AA, Kingsnorth A, eds. Advanced Surgical Practice. London: Greenwich Medical Media, pp. 146-156.
24. Mosteller RD, (1987) Simplified calculation of body-surface area. N Engl J Med 317: 1098.
25. Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE, (2004) Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res 12: 1995-2004.
26. Davison KK, Ford ES, Cogswell ME, Dietz WH, (2002) Percentage of body fat and body mass index are associated with mobility limitations in people aged 70 and older from NHANES III. J Am Geriatr Soc 50: 1802-1809.
27. Prado CM, Wells JC, Smith SR, Stephan BC, Siervo M, (2012) Sarcopenic obesity: a critical appraisal of the current evidence. Clin Nutr 31: 583-601.
28. Marang-van de Mheen PJ, Stadlander MC, Kievit J, (2006) Adverse outcomes in surgical patients: implementation of a nationwide reporting system. Qual Saf Health Care 15: 320-324.
29. Dindo D, Demartines N, Clavien PA, (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240: 205-213.
30. van den Broek MA, van Dam RM, van Breukelen GJ, Bemelmans MH, Oussoultzoglou E, Pessaux P, et al. (2011) Development of a composite endpoint for randomized controlled trials in liver surgery. Br J Surg 98: 1138-1145.
31. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147: 755-763.
32. Tisdale MJ, (2002) Cachexia in cancer patients. Nat Rev Cancer 2: 862-871.
33. Valentijn TM, Galal W, Tjeertes EK, Hoeks SE, Verhagen HJ, Stolker RJ, (2013) The obesity paradox in the surgical population. Surgeon 11: 169-176.
34. Rogde AJ, Gudbrandsdottir G, Hjelle KM, Sand KE, Bostad L, Beisland C, (2012) Obesity is associated with an improved cancer-specific survival, but an increased rate of postoperative complications after surgery for renal cell carcinoma. Scand J Urol Nephrol 46: 348-357.
35. Vigano L, Kluger MD, Laurent A, Tayar C, Merle JC, Lauzet JY, et al. (2011) Liver resection in obese patients: results of a case-control study. HPB 13: 103-111.
36. Mathur A, Franco ES, Leone JP, Osman-Mohamed H, Rojas H, Kemmer N, et al. (2013) Obesity portends increased morbidity and earlier recurrence following liver transplantation for hepatocellular carcinoma. HPB 15: 504-510.
37. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39: 412-423.